Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Pollak

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Breast Cancer Research and Treatment|March 27, 1998
Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and preventionM N Pollak
Computer Programs in Biomedicine|June 1, 1983
Computer-aided information management systems in clinical trials. A physician's perspectiveM N Pollak
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 6, 1998
Mechanisms of antineoplastic action of somatostatin analogsM N Pollak, A V Schally
Biochemical and Biophysical Research Communications|January 14, 1994
Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferationS E Pratt, M N Pollak
Cancer Research|November 1, 1993
Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned mediaS E Pratt, M N Pollak
Journal of the National Cancer Institute|February 21, 1990
Insulinlike growth factor I: a potent mitogen for human osteogenic sarcomaM N Pollak, C Polychronakos, M Richard
Anticancer Research|July 1, 1989
Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-IM N Pollak, C Polychronakos, H Guyda
Biochemical and Biophysical Research Communications|July 15, 1988
Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cellsM N Pollak, C Polychronakos, S Yousefi, et al.
Breast Cancer Research and Treatment|January 1, 1992
Tamoxifen reduces serum insulin-like growth factor I (IGF-I)M N Pollak, H T Huynh, S P Lefebvre
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Direct effects of tamoxifen on growth hormone secretion by pituitary cells in vitroS A Malaab, M N Pollak, C G Goodyer
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Breast Cancer Research and Treatment|March 27, 1998
Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and preventionM N Pollak
Computer Programs in Biomedicine|June 1, 1983
Computer-aided information management systems in clinical trials. A physician's perspectiveM N Pollak
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 6, 1998
Mechanisms of antineoplastic action of somatostatin analogsM N Pollak, A V Schally
Biochemical and Biophysical Research Communications|January 14, 1994
Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferationS E Pratt, M N Pollak
Cancer Research|November 1, 1993
Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned mediaS E Pratt, M N Pollak
Journal of the National Cancer Institute|February 21, 1990
Insulinlike growth factor I: a potent mitogen for human osteogenic sarcomaM N Pollak, C Polychronakos, M Richard
Anticancer Research|July 1, 1989
Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-IM N Pollak, C Polychronakos, H Guyda
Biochemical and Biophysical Research Communications|July 15, 1988
Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cellsM N Pollak, C Polychronakos, S Yousefi, et al.
Breast Cancer Research and Treatment|January 1, 1992
Tamoxifen reduces serum insulin-like growth factor I (IGF-I)M N Pollak, H T Huynh, S P Lefebvre
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Direct effects of tamoxifen on growth hormone secretion by pituitary cells in vitroS A Malaab, M N Pollak, C G Goodyer
Pageof 4